CD117

edit
V-kit Hardi-Zakerman 4, homolog mačijeg sarkoma viralnog onkogena

PDB prikaz baziran na 1pkg.
Dostupne strukture
1PKG, 1T45, 1T46, 2E9W, 2EC8, 2VIF, 3G0E, 3G0F
Identifikatori
SimboliKIT; C-Kit; CD117; PBT; SCFR
Vanjski IDOMIM: 164920 MGI: 96677 HomoloGene: 187 GeneCards: KIT Gene
EC broj2.7.10.1
Ontologija gena
Molekularna funkcija vezivanje nukleotida
vezivanje proteaza
aktivnost proteinske tirozinske kinaze
aktivnost transmembranskog receptora proteinske tirozinske kinaze
aktivnost receptorskog signalnog proteina tirozinske kinaze
receptorska aktivnost
aktivnost faktora receptora stem ćelija
proteinsko vezivanje
ATP vezivanje
citokinsko vezivanje
aktivnost proteinske homodimerizacije
vezivanje metalnog jona
Celularna komponenta ekstracelularni prostor
nukleus
citoplazma
ćelijska membrana
spoljašnja strana ćelijske membrane
integralno sa membranom
Biološki proces aktivacija MAPK aktivnosti
diferencijacija mijeloidnih progenitornih ćelija
diferencijacija limfoidnih progenitornih ćelija
glikosfingolipidni metabolički proces
prenos signala
signalni put transmembranskog receptora proteinske tirozinske kinaze
kaskada intracelularne proteinske kinaze
spermatogeneza
razvoj spermatida
pozitivna regulacija ćelijske proliferacije
razvoj muških gonada
respons na radijaciju
pozitivna regulacija genske ekspresije
pozitivna regulacija fosfolipaze C
pozitivna regulacija kaskade fosfatidilinozitol 3-kinaze
peptidil-tirozinska fosforilacija
citokinom posredovani signalni put
održavanje matičnih ćelija
prenos signala fosforilacijom
Ortolozi
VrstaČovekMiš
Entrez381516590
EnsemblENSG00000157404ENSMUSG00000005672
UniProtP10721P05532
RefSeq (mRNA)NM_000222.2NM_001122733.1
RefSeq (protein)NP_000213.1NP_001116205.1
Lokacija (UCSC)Chr 4:
55.52 - 55.61 Mb
Chr 5:
75.97 - 76.05 Mb
PubMed pretraga[1][2]

Receptor faktora rasta mastocita/matičnih ćelija (engl. Mast/stem cell growth factor receptor - SCFR), takođe poznat kao proto-onkogen c-Kit ili tirozinska proteinska kinaza Kit ili CD117, je protein koji je kod ljudi kodiran KIT genom.[1] Višestruke transkriptne varijante koje kodiraju različite izoforme ovog gena su poznate.[2] KIT prvi opisao nemački biohemičar Aksel Ulrič 1987. kao ćelijski homolog mačijeg sarkomnog viralnog onkogena v-kit.[3]

Interakcije

CD117 formira interakcije sa:

Reference

  1. Andre C, Hampe A, Lachaume P, Martin E, Wang XP, Manus V, Hu WX, Galibert F (January 1997). „Sequence analysis of two genomic regions containing the KIT and the FMS receptor tyrosine kinase genes”. Genomics 39 (2): 216–26. DOI:10.1006/geno.1996.4482. PMID 9027509. 
  2. „Entrez Gene: KIT v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog”. 
  3. Yarden Y, Kuang WJ, Yang-Feng T, Coussens L, Munemitsu S, Dull TJ, Chen E, Schlessinger J, Francke U, Ullrich A (November 1987). „Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand”. EMBO J. 6 (11): 3341–51. PMC 553789. PMID 2448137. 
  4. Wollberg P, Lennartsson J, Gottfridsson E, Yoshimura A, Rönnstrand L (March 2003). „The adapter protein APS associates with the multifunctional docking sites Tyr-568 and Tyr-936 in c-Kit”. Biochem. J. 370 (Pt 3): 1033–8. DOI:10.1042/BJ20020716. PMC 1223215. PMID 12444928. 
  5. Hallek M, Danhauser-Riedl S, Herbst R, Warmuth M, Winkler A, Kolb HJ, Druker B, Griffin JD, Emmerich B, Ullrich A (July 1996). „Interaction of the receptor tyrosine kinase p145c-kit with the p210bcr/abl kinase in myeloid cells”. Br. J. Haematol. 94 (1): 5–16. DOI:10.1046/j.1365-2141.1996.6102053.x. PMID 8757502. 
  6. 6,0 6,1 6,2 Anzai N, Lee Y, Youn BS, Fukuda S, Kim YJ, Mantel C, Akashi M, Broxmeyer HE (June 2002). „C-kit associated with the transmembrane 4 superfamily proteins constitutes a functionally distinct subunit in human hematopoietic progenitors”. Blood 99 (12): 4413–21. DOI:10.1182/blood.V99.12.4413. PMID 12036870. 
  7. 7,0 7,1 Lennartsson J, Wernstedt C, Engström U, Hellman U, Rönnstrand L (August 2003). „Identification of Tyr900 in the kinase domain of c-Kit as a Src-dependent phosphorylation site mediating interaction with c-Crk”. Exp. Cell Res. 288 (1): 110–8. DOI:10.1016/S0014-4827(03)00206-4. PMID 12878163. 
  8. 8,0 8,1 van Dijk TB, van Den Akker E, Amelsvoort MP, Mano H, Löwenberg B, von Lindern M (November 2000). „Stem cell factor induces phosphatidylinositol 3'-kinase-dependent Lyn/Tec/Dok-1 complex formation in hematopoietic cells”. Blood 96 (10): 3406–13. PMID 11071635. 
  9. Sattler M, Salgia R, Shrikhande G, Verma S, Pisick E, Prasad KV, Griffin JD (April 1997). „Steel factor induces tyrosine phosphorylation of CRKL and binding of CRKL to a complex containing c-kit, phosphatidylinositol 3-kinase, and p120(CBL)”. J. Biol. Chem. 272 (15): 10248–53. DOI:10.1074/jbc.272.15.10248. PMID 9092574. 
  10. 10,0 10,1 Liang X, Wisniewski D, Strife A, Shivakrupa, Clarkson B, Resh MD (April 2002). „Phosphatidylinositol 3-kinase and Src family kinases are required for phosphorylation and membrane recruitment of Dok-1 in c-Kit signaling”. J. Biol. Chem. 277 (16): 13732–8. DOI:10.1074/jbc.M200277200. PMID 11825908. 
  11. 11,0 11,1 Voisset E, Lopez S, Chaix A, Vita M, George C, Dubreuil P, De Sepulveda P (February 2010). „FES kinase participates in KIT-ligand induced chemotaxis”. Biochem. Biophys. Res. Commun. 393 (1): 174–8. DOI:10.1016/j.bbrc.2010.01.116. PMID 20117079. 
  12. Jahn T, Seipel P, Urschel S, Peschel C, Duyster J (February 2002). „Role for the adaptor protein Grb10 in the activation of Akt”. Mol. Cell. Biol. 22 (4): 979–91. DOI:10.1128/MCB.22.4.979-991.2002. PMC 134632. PMID 11809791. 
  13. 13,0 13,1 13,2 De Sepulveda P, Okkenhaug K, Rose JL, Hawley RG, Dubreuil P, Rottapel R (February 1999). „Socs1 binds to multiple signalling proteins and suppresses steel factor-dependent proliferation”. EMBO J. 18 (4): 904–15. DOI:10.1093/emboj/18.4.904. PMC 1171183. PMID 10022833. 
  14. Thömmes K, Lennartsson J, Carlberg M, Rönnstrand L (July 1999). „Identification of Tyr-703 and Tyr-936 as the primary association sites for Grb2 and Grb7 in the c-Kit/stem cell factor receptor”. Biochem. J. 341 ( Pt 1): 211–6. DOI:10.1042/0264-6021:3410211. PMC 1220349. PMID 10377264. 
  15. Feng GS, Ouyang YB, Hu DP, Shi ZQ, Gentz R, Ni J (May 1996). „Grap is a novel SH3-SH2-SH3 adaptor protein that couples tyrosine kinases to the Ras pathway”. J. Biol. Chem. 271 (21): 12129–32. DOI:10.1074/jbc.271.21.12129. PMID 8647802. 
  16. Lev S, Yarden Y, Givol D (May 1992). „A recombinant ectodomain of the receptor for the stem cell factor (SCF) retains ligand-induced receptor dimerization and antagonizes SCF-stimulated cellular responses”. J. Biol. Chem. 267 (15): 10866–73. PMID 1375232. 
  17. Blechman JM, Lev S, Brizzi MF, Leitner O, Pegoraro L, Givol D, Yarden Y (February 1993). „Soluble c-kit proteins and antireceptor monoclonal antibodies confine the binding site of the stem cell factor”. J. Biol. Chem. 268 (6): 4399–406. PMID 7680037. 
  18. Gueller S, Gery S, Nowak V, Liu L, Serve H, Koeffler HP (October 2008). „Adaptor protein Lnk associates with Tyr(568) in c-Kit”. Biochem. J. 415 (2): 241–5. DOI:10.1042/BJ20080102. PMID 18588518. 
  19. Linnekin D, DeBerry CS, Mou S (October 1997). „Lyn associates with the juxtamembrane region of c-Kit and is activated by stem cell factor in hematopoietic cell lines and normal progenitor cells”. J. Biol. Chem. 272 (43): 27450–5. DOI:10.1074/jbc.272.43.27450. PMID 9341198. 
  20. Jhun BH, Rivnay B, Price D, Avraham H (April 1995). „The MATK tyrosine kinase interacts in a specific and SH2-dependent manner with c-Kit”. J. Biol. Chem. 270 (16): 9661–6. DOI:10.1074/jbc.270.16.9661. PMID 7536744. 
  21. Price DJ, Rivnay B, Fu Y, Jiang S, Avraham S, Avraham H (February 1997). „Direct association of Csk homologous kinase (CHK) with the diphosphorylated site Tyr568/570 of the activated c-KIT in megakaryocytes”. J. Biol. Chem. 272 (9): 5915–20. DOI:10.1074/jbc.272.9.5915. PMID 9038210. 
  22. Mancini A, Koch A, Stefan M, Niemann H, Tamura T (September 2000). „The direct association of the multiple PDZ domain containing proteins (MUPP-1) with the human c-Kit C-terminus is regulated by tyrosine kinase activity”. FEBS Lett. 482 (1-2): 54–8. DOI:10.1016/S0014-5793(00)02036-6. PMID 11018522. 
  23. Serve H, Hsu YC, Besmer P (February 1994). „Tyrosine residue 719 of the c-kit receptor is essential for binding of the P85 subunit of phosphatidylinositol (PI) 3-kinase and for c-kit-associated PI 3-kinase activity in COS-1 cells”. J. Biol. Chem. 269 (8): 6026–30. PMID 7509796. 
  24. Tauchi T, Feng GS, Marshall MS, Shen R, Mantel C, Pawson T, Broxmeyer HE (October 1994). „The ubiquitously expressed Syp phosphatase interacts with c-kit and Grb2 in hematopoietic cells”. J. Biol. Chem. 269 (40): 25206–11. PMID 7523381. 
  25. 25,0 25,1 Kozlowski M, Larose L, Lee F, Le DM, Rottapel R, Siminovitch KA (April 1998). „SHP-1 binds and negatively modulates the c-Kit receptor by interaction with tyrosine 569 in the c-Kit juxtamembrane domain”. Mol. Cell. Biol. 18 (4): 2089–99. PMC 121439. PMID 9528781. 
  26. Yi T, Ihle JN (June 1993). „Association of hematopoietic cell phosphatase with c-Kit after stimulation with c-Kit ligand”. Mol. Cell. Biol. 13 (6): 3350–8. PMC 359793. PMID 7684496. 
  27. Deberry C, Mou S, Linnekin D (October 1997). „Stat1 associates with c-kit and is activated in response to stem cell factor”. Biochem. J. 327 ( Pt 1): 73–80. PMC 1218765. PMID 9355737. 
  28. Bayle J, Letard S, Frank R, Dubreuil P, De Sepulveda P (March 2004). „Suppressor of cytokine signaling 6 associates with KIT and regulates KIT receptor signaling”. J. Biol. Chem. 279 (13): 12249–59. DOI:10.1074/jbc.M313381200. PMID 14707129. 
  29. Lennartsson J, Blume-Jensen P, Hermanson M, Pontén E, Carlberg M, Rönnstrand L (September 1999). „Phosphorylation of Shc by Src family kinases is necessary for stem cell factor receptor/c-kit mediated activation of the Ras/MAP kinase pathway and c-fos induction”. Oncogene 18 (40): 5546–53. DOI:10.1038/sj.onc.1202929. PMID 10523831. 
  30. Tang B, Mano H, Yi T, Ihle JN (December 1994). „Tec kinase associates with c-kit and is tyrosine phosphorylated and activated following stem cell factor binding”. Mol. Cell. Biol. 14 (12): 8432–7. PMC 359382. PMID 7526158. 

Literatura

  • Lennartsson J, Rönnstrand L (2006). „The stem cell factor receptor/c-Kit as a drug target in cancer”. Curr. Cancer Drug Targ. 6 (1): 65–75. DOI:10.2174/156800906775471725. PMID 16475976. 
  • Rönnstrand L (2004). „Signal transduction via the stem cell factor receptor/c-Kit”. Cell. Mol. Life Sci. 61 (19–20): 2535–2548. DOI:10.1007/s00018-004-4189-6. PMID 15526160. 
  • Linnekin D (2000). „Early signaling pathways activated by c-Kit in hematopoietic cells”. Int. J. Biochem. Cell Biol. 31 (10): 1053–74. DOI:10.1016/S1357-2725(99)00078-3. PMID 10582339. 
  • Canonico B, Felici C, Papa S (2001). „CD117”. J. Biol. Regul. Homeost. Agents 15 (1): 90–4. PMID 11388751. 
  • Gupta R, Bain BJ, Knight CL (2002). „Cytogenetic and molecular genetic abnormalities in systemic mastocytosis”. Acta Haematol. 107 (2): 123–8. DOI:10.1159/000046642. PMID 11919394. 
  • Valent P, Ghannadan M, Hauswirth AW, et al. (2003). „Signal transduction-associated and cell activation-linked antigens expressed in human mast cells”. Int. J. Hematol. 75 (4): 357–62. DOI:10.1007/BF02982124. PMID 12041664. 
  • Sandberg AA, Bridge JA (2002). „Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors. gastrointestinal stromal tumors”. Cancer Genet. Cytogenet. 135 (1): 1–22. DOI:10.1016/S0165-4608(02)00546-0. PMID 12072198. 
  • Kitamura Y, Hirotab S (2005). „Kit as a human oncogenic tyrosine kinase”. Cell. Mol. Life Sci. 61 (23): 2924–31. DOI:10.1007/s00018-004-4273-y. PMID 15583854. 
  • Larizza L, Magnani I, Beghini A (2005). „The Kasumi-1 cell line: a t(8;21)-kit mutant model for acute myeloid leukemia”. Leuk. Lymphoma 46 (2): 247–55. DOI:10.1080/10428190400007565. PMID 15621809. 
  • Miettinen M, Lasota J (2006). „KIT (CD117): a review on expression in normal and neoplastic tissues, and mutations and their clinicopathologic correlation”. Appl. Immunohistochem. Mol. Morphol. 13 (3): 205–20. PMID 16082245. 
  • Lasota J, Miettinen M (2007). „KIT and PDGFRA mutations in gastrointestinal stromal tumors (GISTs)”. Semin Diagn Pathol 23 (2): 91–102. DOI:10.1053/j.semdp.2006.08.006. PMID 17193822. 
  • Patnaik MM, Tefferi A, Pardanani A (2007). „Kit: molecule of interest for the diagnosis and treatment of mastocytosis and other neoplastic disorders”. Current cancer drug targets 7 (5): 492–503. DOI:10.2174/156800907781386614. PMID 17691909. 
  • Giebel LB, Strunk KM, Holmes SA, Spritz RA (1992). „Organization and nucleotide sequence of the human KIT (mast/stem cell growth factor receptor) proto-oncogene”. Oncogene 7 (11): 2207–17. PMID 1279499. 
  • Spritz RA, Droetto S, Fukushima Y (1992). „Deletion of the KIT and PDGFRA genes in a patient with piebaldism”. Am. J. Med. Genet. 44 (4): 492–5. DOI:10.1002/ajmg.1320440422. PMID 1279971. 
  • Spritz RA, Giebel LB, Holmes SA (1992). „Dominant negative and loss of function mutations of the c-kit (mast/stem cell growth factor receptor) proto-oncogene in human piebaldism”. Am. J. Hum. Genet. 50 (2): 261–9. PMC 1682440. PMID 1370874. 
  • Duronio V, Welham MJ, Abraham S, et al. (1992). „p21ras activation via hemopoietin receptors and c-kit requires tyrosine kinase activity but not tyrosine phosphorylation of p21ras GTPase-activating protein”. Proc. Natl. Acad. Sci. U.S.A. 89 (5): 1587–91. DOI:10.1073/pnas.89.5.1587. PMC 48497. PMID 1371879. 
  • André C, Martin E, Cornu F, et al. (1992). „Genomic organization of the human c-kit gene: evolution of the receptor tyrosine kinase subclass III”. Oncogene 7 (4): 685–91. PMID 1373482. 
  • Lev S, Yarden Y, Givol D (1992). „A recombinant ectodomain of the receptor for the stem cell factor (SCF) retains ligand-induced receptor dimerization and antagonizes SCF-stimulated cellular responses”. J. Biol. Chem. 267 (15): 10866–73. PMID 1375232. 
  • Fleischman RA (1992). „Human piebald trait resulting from a dominant negative mutant allele of the c-kit membrane receptor gene”. J. Clin. Invest. 89 (6): 1713–7. DOI:10.1172/JCI115772. PMC 295855. PMID 1376329. 
  • Vandenbark GR, deCastro CM, Taylor H, et al. (1992). „Cloning and structural analysis of the human c-kit gene”. Oncogene 7 (7): 1259–66. PMID 1377810. 
  • Alai M, Mui AL, Cutler RL, et al. (1992). „Steel factor stimulates the tyrosine phosphorylation of the proto-oncogene product, p95vav, in human hemopoietic cells”. J. Biol. Chem. 267 (25): 18021–5. PMID 1381360. 
  • Ashman LK, Cambareri AC, To LB, et al. (1991). „Expression of the YB5.B8 antigen (c-kit proto-oncogene product) in normal human bone marrow”. Blood 78 (1): 30–7. PMID 1712644. 

Vidi još

Vanjske veze

  • p
  • r
  • u
PDB Galerija
1pkg: Struktura kompleksa c-Kit kinaze
1pkg: Struktura kompleksa c-Kit kinaze  
1t45: Strukturna osnova autoinhibicije i STI-571 inhibicije C-KIT tirozinske kinaze
1t45: Strukturna osnova autoinhibicije i STI-571 inhibicije C-KIT tirozinske kinaze  
1t46: Strukturna osnova autoinhibicije i STI-571 inhibicije C-KIT tirozinske kinaze
1t46: Strukturna osnova autoinhibicije i STI-571 inhibicije C-KIT tirozinske kinaze  
  • p
  • r
  • u
1-50
CD1 (a-c, 1A, 1D, 1E) • CD2 • CD3 (γ, δ, ε) • CD4 • CD5 • CD6 • CD7 • CD8 (a) • CD9 • CD10 • CD11 (a, b, c) • CD13 • CD14 • CD15 • CD16 (A, B) • CD18 • CD19 • CD20 • CD21 • CD22 • CD23 • CD24 • CD25 • CD26 • CD27 • CD28 • CD29 • CD30 • CD31 • CD32 (A, B) • CD33 • CD34 • CD35 • CD36 • CD37 • CD38 • CD39 • CD40 • CD41 • CD42 (a, b, c, d) • CD43 • CD44 • CD45 • CD46 • CD47 • CD48 • CD49 (a, b, c, d, e, f) • CD50
51-100
CD51 • CD52 • CD53 • CD54 • CD55 • CD56 • CD57 • CD58 • CD59 • CD61 • CD62 (E, L, P) • CD63 • CD64 (A, B, C) • CD66 (a, b, c, d, e, f) • CD68 • CD69 • CD70 • CD71 • CD72 • CD73 • CD74 • CD78 • CD79 (a, b) • CD80 • CD81 • CD82 • CD83 • CD84 • CD85 (a, d, e, h, j, k) • CD86 • CD87 • CD88 • CD89 • CD90 • CD91- CD92 • CD93 • CD94 • CD95 • CD96 • CD97 • CD98 • CD99 • CD100
101-150
CD101 • CD102 • CD103 • CD104 • CD105 • CD106 • CD107 (a, b) • CD108 • CD109 • CD110 • CD111 • CD112 • CD113 • CD114 • CD115 • CD116 • CD117 • CD118 • CD119 • CD120 (a, b) • CD121 (a, b) • CD122 • CD123 • CD124 • CD125 • CD126 • CD127 • CD129 • CD130 • CD131 • CD132 • CD133 • CD134 • CD135 • CD136 • CD137 • CD138 • CD140b • CD141 • CD142 • CD143 • CD144 • CD146 • CD147 • CD148 • CD150
151-200
CD151 • CD152 • CD153 • CD154 • CD155 • CD156 (a, b, c) • CD157 • CD158 (a, d, e, i, k) • CD159 (a, c) • CD160 • CD161 • CD162 • CD163 • CD164 • CD166 • CD167 (a, b) • CD168 • CD169 • CD170 • CD171 • CD172 (a, b, g) • CD174 • CD177 • CD178 • CD179 (a, b) • CD181 • CD182 • CD183 • CD184 • CD185 • CD186 • CD191 • CD192 • CD193 • CD194 • CD195 • CD196 • CD197 • CDw198 • CDw199 • CD200
201-250
CD201 • CD202b • CD204 • CD205 • CD206 • CD207 • CD208 • CD209 • CDw210 (a, b) • CD212 • CD213a (1, 2) • CD217 • CD218 (a, b) • CD220 • CD221 • CD222 • CD223 • CD224 • CD225 • CD226 • CD227 • CD228 • CD229 • CD230 • CD233 • CD234 • CD235 (a, b) • CD236 • CD238 • CD239 • CD240CE • CD241 • CD243 • CD244 • CD246 • CD247- CD248 • CD249
251-300
CD252 • CD253 • CD254 • CD256 • CD257 • CD258 • CD261 • CD262 • CD264 • CD265 • CD266 • CD267 • CD268 • CD269 • CD271 • CD272 • CD273 • CD274 • CD275 • CD276 • CD278 • CD279 • CD280 • CD281 • CD282 • CD283 • CD284 • CD286 • CD288 • CD289 • CD290 • CD292 • CDw293 • CD294 • CD295 • CD297 • CD298 • CD299
301-350
CD300A • CD301 • CD302 • CD303 • CD304 • CD305 • CD306 • CD307 • CD309 • CD312 • CD314 • CD315 • CD316 • CD317 • CD318 • CD320 • CD321 • CD322 • CD324 • CD325 • CD326 • CD328 • CD329 • CD331 • CD332 • CD333 • CD334 • CD335 • CD336 • CD337 • CD338 • CD339 • CD340 • CD344 • CD349 • CD350
  • p
  • r
  • u
Nervni faktori rasta
niski afinitet/p75 - visok afinitet Trk (TrkA, TrkB, TrkC) - Cilijarni neurotrofni faktor
Somatomedin
CSF
Stem ćelijski faktor - Eritropoietin
TGF put
TGF-beta (1, 2) - Aktivin (1, 2) - Bone morfogenetski protein (1, 2)
Drugi
vidi isto Faktori rasta
B trdu: peptidi (nrpl/grfl/cytl/horl), receptori (lgic, enzr, gprc, igsr, intg, nrpr/grfr/cytr), itra (adap, gbpr, mapk), calc, lipd, signalni putevi (hedp, wntp, tgfp+mapp, notp, jakp, fsap, hipp, tlrp)
  • p
  • r
  • u
Hemokinski receptor
(GPCR)
CC hemokinski receptori
CCR1  CCRL1  CCR2  CCRL2  CCR3  CCR4  CCR5  CCR6  CCR7  CCR8  CCR9  CCR10
CXC hemokinski receptori
IL-8 (CXCR1, CXCR2)  CXCR3  CXCR4  CXCR5  CXCR6  CXCR7
Drugi
CCBP2  CMKLR1  CX3CR1  XCR1
TNF receptor
1-10
TNFRSF1 (CD120)  TNFRSF1A (CD120a)  TNFRSF1B (CD120b)  TNFRSF3 (Limfotoksin beta receptor)  TNFRSF4 (CD134)  TNFRSF5 (CD40)  TNFRSF6 (FAS)  TNFRSF6B  TNFRSF7 (CD27)  TNFRSF8 (CD30)  TNFRSF9 (CD137)
11-20
TNFRSF10A (CD261)  TNFRSF10B (CD262)  TNFRSF10C (CD263)  TNFRSF10D (CD264)  TNFRSF11A (CD265/RANK)  TNFRSF11B (Osteoprotegerin)  TNFRSF12A (CD266)  TNFRSF13B (CD267)  TNFRSF13C  TNFRSF14 (CD268)  TNFRSF16 (Receptor nervnog faktora rasta)  TNFRSF17 (CD269)  TNFRSF18  TNFRSF19
21-25
TNFRSF21  TNFRSF25  TNFRSF27
JAK-STAT
zajednički beta lanac: Interleukinski receptori (3, 5)  GM-CSF

zajednički gama lanac: Interleukinski receptori (2, 4, 7, 9, 13/A1/A2, 15, 21)

gp130 koristeći: Interleukinski receptori (6, 27)  Onkostatin M  Leukemija inhibitorni faktor

drugi Interleukinski receptori (11/A, 12/B1/B2, 23)

drugi CSF receptori (EPO, G-CSF, Trombopoietin)

Hormonski receptor: GH  prolaktin
Tip II
Interleukini (10, 20, 22, 28)  interferon (-α/β, -γ)
Ig superfamilija
CSF1  C-kit  IL-1 (IL1R1, IL1R2)  IL-18
S/T
TGF-beta (1, 2)
Drugi
IL-17 (IL17RA, IL17RB, IL17RC, IL17RD, IL17RE)
B trdu: peptidi (nrpl/grfl/cytl/horl), receptori (lgic, enzr, gprc, igsr, intg, nrpr/grfr/cytr), itra (adap, gbpr, mapk), calc, lipd, signalni putevi (hedp, wntp, tgfp+mapp, notp, jakp, fsap, hipp, tlrp)
  • p
  • r
  • u
  • p
  • r
  • u
Receptori faktora rasta
EGFR • ERBB2 • ERBB3 • ERBB4
IGF1R • INSR • INSRR
CSF1R • FLT3 • KIT • PDGFR (PDGFRA, PDGFRB)
FGFR1 • FGFR2 • FGFR3 • FGFR4
VEGFR1 • VEGFR2 • VEGFR3 • VEGFR4
MET • RON
NTRK1 • NTRK2 • NTRK3
EPH receptorska familija
EPHA1 • EPHA2 • EPHA3 • EPHA4 • EPHA5 • EPHA6 • EPHA7 • EPHA8 • EPHB1 • EPHB2 • EPHB3 • EPHB4 • EPHB5 • EPHB6 • EPHX
LTK receptorska familija
LTK • ALK
TIE receptorska familija
TIE • TEK
ROR receptorska familija
ROR1 • ROR2
DDR receptorska familija
DDR1 • DDR2
PTK7 receptorska familija
RYK receptorska familija
MuSK receptorska familija
ROS receptorska familija
ROS1
AATYK receptorska familija
AATYK • AATYK2 • AATYK3
AXL receptorska familija
AXL • MER • TYRO3
RET receptorska familija
nekategorisani
  • p
  • r
  • u
ABL familija
ABL1 • ARG
ACK familija
ACK1 • TNK1
CSK familija
CSK • MATK
FAK familija
FAK • PYK2
FES familija
FES • FER
FRK familija
FRK • BRK • SRMS
JAK familija
JAK1 • JAK2 • JAK3 • TYK2
SRC-A familija
SRC • FGR • FYN • YES1
SRC-B familija
BLK • HCK • LCK • LYN
TEC familija
TEC • BMX • BTK • ITK • TXK
SYK familija
SYK • ZAP70
B enzm: 1.1/2/3/4/5/6/7/8/10/11/13/14/15-18, 2.1/2/3/4/5/6/7/8, 2.7.10, 2.7.11-12, 3.1/2/3/4/5/6/7, 3.1.3.48, 3.4.21/22/23/24, 4.1/2/3/4/5/6, 5.1/2/3/4/99, 6.1-3/4/5-6
  • p
  • r
  • u
Teme
Tipovi
EC1 Oksidoreduktaze/spisak  • EC2 Transferaze/spisak  • EC3 Hidrolaze/spisak  • EC4 Lijaze/spisak  • EC5 Izomeraze/spisak  • EC6 Ligaze/spisak
B enzm: 1.1/2/3/4/5/6/7/8/10/11/13/14/15-18, 2.1/2/3/4/5/6/7/8, 2.7.10, 2.7.11-12, 3.1/2/3/4/5/6/7, 3.1.3.48, 3.4.21/22/23/24, 4.1/2/3/4/5/6, 5.1/2/3/4/99, 6.1-3/4/5-6